WebFind the latest SEC Filings data for Gilead Sciences, Inc. Common Stock (GILD) at Nasdaq.com. WebApr 14, 2024 · The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.16% of the stock is owned by insiders. Gilead Sciences Profile . Gilead Sciences, Inc is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.
Gilead Sciences, Inc. - Events & Presentations - Nasdaq
WebFeb 25, 2024 · Gilead Sciences, Inc. - Financials - SEC Filings - SEC Filings Details. WebAt Gilead, we promise to treat your data with respect. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance. shipbucket ottoman navy
Gilead to Acquire Forty Seven for $4.9 Billion Business Wire
WebApr 14, 2024 · Gilead Sciences had a return on equity of 44.46% and a net margin of 16.83%. The company had revenue of $7.39 billion for the quarter, compared to analysts’ expectations of $6.63 billion. WebDec 31, 2024 · Gilead Sciences, Inc. (“Gilead,” “we,” “our” or “us”) is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three … WebApr 11, 2024 · The fund owned 19,542 shares of the biopharmaceutical company's stock after purchasing an additional 2,441 shares during the period. Signaturefd LLC's holdings in Gilead Sciences were worth $1,678,000 as of its most recent filing with the SEC. Downturn Gives These 3 Buys Juicy Dividend Yields. A number of other institutional investors have … shipbucket rifles